Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
Apply
Emavusertib & Chemoimmunotherapy
Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step